Alistair Dunn
 
Alistair Dunn graduated from Auckland Medical School in 1985 , and has worked in General Practice in Whangarei for the last 20 years , gaining FRNZCGP in 1998 . During this time he has also worked part time for the Northland DHB Alcohol & Drug service , and gained fellowship to the Australasian Chapter of Addiction Medicine in 2004 ( FAChAM ).

 

 

Buprenorphine as a New Opiate Substitute
Concurrent Workshop Repeated
Friday, 13 June 2014 Start 11:00am Duration: 55mins Room 8
Start 12:05pm Duration: 55mins Room 8
Buprenorphine as a new opiate substitute therapy – “Back to the Future” 

Many GPs will remember Buprenorphine ( Bup ) as “Temgesic”, a sublingual opiate analgesic used in the 1980s and 90s. Unfortunately it became very popular among injecting drug users and was eventually taken off the market. 

Now Bup is back , as “Suboxone” , a combination of Bup and Naloxone. This sublingual medication was subsidised by PHARMAC in July 2012 for use in opiate detox and also in opiate substitution treatment ( OST ), as an alternative to methadone.

This presentation reviews the pharmacology of Suboxone, compares it with methadone, and discusses the implications of its use in General Practice
   

Methamphetamines and Legal Highs
Concurrent Workshop Repeated
Friday, 13 June 2014 Start 4:30pm Duration: 55mins Room 1
Start 5:35pm Duration: 55mins Room 1

PRESENTATION: PDF of Presentation